Zesheng Li
Key Laboratory Of Post Neuroinjury Neuro Repair And Regeneration In Central Nervous System, 154 Anshan Road
Xiaobailou, 300052, China
Xiaobailou, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Leveraging pathological markers of lower grade glioma to predict the occurrence of secondary epilepsy, a retrospective study.
Journal: Scientific reports
Published: September 12, 2024
A novel protein SPECC1-415aa encoded by N6-methyladenosine modified circSPECC1 regulates the sensitivity of glioblastoma to TMZ.
Journal: Cellular & molecular biology letters
Published: May 04, 2024
ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification.
Journal: Frontiers in pharmacology
Published: January 23, 2024
A three-stage eccDNA based molecular profiling significantly improves the identification, prognosis assessment and recurrence prediction accuracy in patients with glioma.
Journal: Cancer letters
Published: June 29, 2023
Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
Journal: Frontiers in pharmacology
Published: February 01, 2023
Machine learning-based integration develops biomarkers initial the crosstalk between inflammation and immune in acute myocardial infarction patients.
Journal: Frontiers in cardiovascular medicine
Published: October 01, 2022
PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas.
Journal: Frontiers in oncology
Published: September 27, 2022
Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Journal: Frontiers in immunology
Published: May 15, 2022
Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
Journal: International journal of biological sciences
Published: March 31, 2022
Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Journal: Frontiers in immunology
Published: January 06, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026